List of insiders holdings for Viridian Therapeutics, Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
Fairmount Funds Management LLC
Fairmount Healthcare Fund GP LLC
Fairmount Healthcare Fund II GP LLC
Fairmount Healthcare Fund L.P.
Fairmount Healthcare Fund II L.P.
See Remarks
10% Owner		2022-08-19 16:34:309,192,814
0		9,192,814Form 13D
Atlas Venture Fund VII L P
10% Owner		2017-02-23 14:47:523,142,580
0		3,142,580Form 13D
Remeditex Ventures LLC
10% Owner		2017-02-17 16:00:572,706,563
0		2,706,563Form 13G
LEBOW BENNETT S
LEBOW ALPHA LLLP
Director
10% Owner		2015-02-11 10:50:572,232,629
0		2,232,629Form 13G
LEBOW BENNETT S
Director
10% Owner		2017-02-13 18:05:181,325,600
148,841		1,474,441Form 4
Violin Jonathan
Chief Executive Officer		2023-02-07 18:35:01720,110
0		720,110Form 4/A
Riccitelli Samuel D
President & CEO		2016-11-02 20:37:58571,370
0		571,370Form 4
Logos Global Master Fund LP
10% Owner		2020-11-16 18:23:22550,000
0		550,000Form 4
Point72 Asset Management L.P.
Point72 Capital Advisors Inc.
COHEN STEVEN A/SAC CAPITAL MGMT LP
10% Owner		2022-02-14 16:32:39472,864
0		472,864Form 13G
Leverone Jason A.
Chief Financial Officer		2021-01-20 15:55:20311,785
0		311,785Form 4
Frazier Life Sciences Public Fund L.P.
FHMLSP L.P.
FHMLSP L.L.C.
10% Owner		2022-08-12 12:35:52300,000
0		300,000Form 13G
Myers Scott Dunseth
Chief Executive Officer		2023-03-13 16:06:51255,500
0		255,500Form 4
Katz Barrett
Chief Medical Officer		2023-02-10 16:54:03108,000
0		108,000Form 4
Humer Kristian
CFO and CBO		2023-02-10 16:49:26108,000
0		108,000Form 4
SEYMOUR TAMARA A
CFO, Secretary, Treasurer		2016-11-02 20:39:070
106,447		106,447Form 4
RUBIN PAUL D
EVP, Research & Development		2019-02-08 16:34:5687,000
0		87,000Form 4
Levy Adam Scott
Chief Business Officer		2019-02-08 16:32:3774,000
0		74,000Form 4
Melvin Carrie
COO		2023-02-10 16:51:4854,000
0		54,000Form 4
Hatfield Jeffrey S.
Director		2021-02-08 17:40:2825,000
0		25,000Form 4
TURNER JOSEPH L
Director		2021-02-08 17:41:0325,000
0		25,000Form 4
Bowden Christopher
Director		2020-05-22 17:09:0524,000
0		24,000Form 4
Hughes Thomas E.
Director		2020-05-22 17:13:3324,000
0		24,000Form 4
KOCH KEVIN
Director		2020-05-22 17:16:0824,000
0		24,000Form 4
Schuling Douglas A
Director		2016-06-20 18:46:4618,000
0		18,000Form 4
Rauch Lee M.
See Remarks		2021-01-19 20:04:1415,000
0		15,000Form 4
Harwin Peter Evan
Director		2022-06-10 07:30:140
12,500		12,500Form 4
Moses Jennifer K.
Director		2022-06-10 07:30:2212,500
0		12,500Form 4
Kiselak Tomas
Director		2022-06-10 07:30:180
12,500		12,500Form 4
Morris Arlene
Director		2022-06-10 07:30:1012,500
0		12,500Form 4
LEFKOFF KYLE
Director		2017-06-30 17:24:5612,000
0		12,000Form 4
Booth Bruce
Director		2018-06-28 16:31:4012,000
0		12,000Form 4
Creecy John W
Director		2017-06-30 17:22:1112,000
0		12,000Form 4
Smith Robin L
Director		2017-02-07 21:08:061900
0		1900Form 4
Gonyer David A
Director		2017-02-08 20:50:081899
0		1899Form 4
Johnson Robert Brian
CFO and CAO		2014-06-17 21:36:190
0		0Form 3
Escolar Diana
Former Chief Medical Officer		2021-01-19 20:11:370
0		0Form 4
Marshall William Stuart
See Remarks		2021-01-15 19:47:570
0		0Form 4
Meisner Lara
General Counsel and Secretary		2023-03-10 16:05:120
0		0Form 4
RA CAPITAL MANAGEMENT L.P.
RA Capital Healthcare Fund LP
Kolchinsky Peter
Shah Rajeev M.
10% Owner		2022-02-14 16:11:500
0		0Form 13G